STROMABLAST Trademark

Trademark Overview


On Tuesday, February 18, 2025, a trademark application was filed for STROMABLAST with the United States Patent and Trademark Office. The USPTO has given the STROMABLAST trademark a serial number of 99045443. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 18, 2025. This trademark is owned by Simcere Zaiming, Inc.. The STROMABLAST trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research on the subject of pharmaceuticals; Pharmaceutical research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Scientific research in the field of pharmaceuticals and biotechnology; Medical and scientific research in the field of cancer treatment and diagnosis; Biotechnology research; Scientific research for medical purposes in the area of cancerous diseases; Biological research; ...
stromablast

General Information


Serial Number99045443
Word MarkSTROMABLAST
Filing DateTuesday, February 18, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch on the subject of pharmaceuticals; Pharmaceutical research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Scientific research in the field of pharmaceuticals and biotechnology; Medical and scientific research in the field of cancer treatment and diagnosis; Biotechnology research; Scientific research for medical purposes in the area of cancerous diseases; Biological research; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Providing laboratory research services in the field of gene expression, namely, cancer biology; Biomedical research services; Research and development of vaccines and medicines; Laboratory research services relating to pharmaceuticals; Research and development services in the field of antibodies; Medical research in the field of oncology; Scientific research in the field of genetics and genetic engineering; Medical research services in the field of cancer; Drug screening for scientific research purposes; Research in the field of bioengineering; Research in the field of synthetic biology; Cell culture services for scientific and research purposes, for others; Research in the field of plant genetic engineering technology; Research and development of siRNA drugs; Medical research laboratory services in the field of oncology; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Biochemical research and development services; Research and development services in the field of biotechnology; Research and development services relating to medicines; Research and development of medicines; Research and development services in the field of medical preparations; Research in the field of bioinformatics; Research in the field of immunodeficiency

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 18, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSimcere Zaiming, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Tuesday, February 18, 2025NEW APPLICATION ENTERED
Tuesday, February 18, 2025APPLICATION FILING RECEIPT MAILED